barbara
03-05-2010, 01:39 PM
Don't forget teatime! If anyone is going to this or knows anyone going, it would be nice to get a review of the symposium.
Regenerative Medicine: A New Frontier for Therapeutic Intervention
11th March 2010
Riverside, Granta Park, Great Abington, Cambridge
Regenerative Medicine is one of science?s new horizons, holding the promise of groundbreaking new therapies to repair, replace or regenerate disease damaged cells, tissues or organs. It is a multi-disciplinary field of research which is acquiring increasing importance in drug discovery and development portfolios but the realisation of this promise depends on overcoming a number of significant challenges.
This SMR symposium brings together a panel of international speakers across the breadth of research and development in the field of Regenerative Medicine to present and discuss the advances that are currently being made. Biomedical approaches to novel clinical therapies will be discussed including induction of regeneration by biologically active molecules, stem cell therapies, and tissue engineering. The basic features of embryonic stem cells and how they may lead to human therapies will be highlighted.
A number of case studies on important new approaches to Regenerative Medicine will be presented by both academic and industry leaders in the field, and the challenges of conducting clinical trials in this area will be discussed.
Programme:
09.30 Arrival, Registration and Coffee
09.55 Opening announcements
Session 1 - Chair: Dr. Wendy Alderton
10.00 Dr Stephen Minger, Global Director R&D Cell Technologies, GE Healthcare, UK
Historical Perspective on Stem Cell Research
10.45 Professor Austin Smith , Wellcome Trust Centre for Stem Cell Research, Cambridge University, UK
Fundamental Biology of Stem Cells
11.30 Professor Peter Coffey, Institute of Ophthalmology, University College London, UK
Retinal pigmented epithelial cell therapy for the treatment of age related macular degeneration
12.15 Lunch
Session 2 - Chair: Dr Richard Davenport
13.15 Dr Mark Bunnage, Head of Chemistry, Pfizer Regenerative Medicine, UK
Small molecule approaches for modulation of stem cell activity
14.30 Dr. Paul Kemp, CSO & Founder, Intercytex Ltd, UK
Perspective on the challenges of conducting clinical trials in regenerative medicines
15.15 Tea
Session 3 - Chair: Dr Ruth McKernan
15.45
Dr Eduardo Bravo, CEO of Cellerix, Spain
Ontaril: an autologous adipose tissue treatment
16.30 Dr Koenraad Blot, CMO of TiGenix, Belgium
The making of ChondroCelect: clinical and regulatory successes and challenges
17.15 Closing remarks and thanks ? SMR Chairman
Regenerative Medicine: A New Frontier for Therapeutic Intervention
11th March 2010
Riverside, Granta Park, Great Abington, Cambridge
Regenerative Medicine is one of science?s new horizons, holding the promise of groundbreaking new therapies to repair, replace or regenerate disease damaged cells, tissues or organs. It is a multi-disciplinary field of research which is acquiring increasing importance in drug discovery and development portfolios but the realisation of this promise depends on overcoming a number of significant challenges.
This SMR symposium brings together a panel of international speakers across the breadth of research and development in the field of Regenerative Medicine to present and discuss the advances that are currently being made. Biomedical approaches to novel clinical therapies will be discussed including induction of regeneration by biologically active molecules, stem cell therapies, and tissue engineering. The basic features of embryonic stem cells and how they may lead to human therapies will be highlighted.
A number of case studies on important new approaches to Regenerative Medicine will be presented by both academic and industry leaders in the field, and the challenges of conducting clinical trials in this area will be discussed.
Programme:
09.30 Arrival, Registration and Coffee
09.55 Opening announcements
Session 1 - Chair: Dr. Wendy Alderton
10.00 Dr Stephen Minger, Global Director R&D Cell Technologies, GE Healthcare, UK
Historical Perspective on Stem Cell Research
10.45 Professor Austin Smith , Wellcome Trust Centre for Stem Cell Research, Cambridge University, UK
Fundamental Biology of Stem Cells
11.30 Professor Peter Coffey, Institute of Ophthalmology, University College London, UK
Retinal pigmented epithelial cell therapy for the treatment of age related macular degeneration
12.15 Lunch
Session 2 - Chair: Dr Richard Davenport
13.15 Dr Mark Bunnage, Head of Chemistry, Pfizer Regenerative Medicine, UK
Small molecule approaches for modulation of stem cell activity
14.30 Dr. Paul Kemp, CSO & Founder, Intercytex Ltd, UK
Perspective on the challenges of conducting clinical trials in regenerative medicines
15.15 Tea
Session 3 - Chair: Dr Ruth McKernan
15.45
Dr Eduardo Bravo, CEO of Cellerix, Spain
Ontaril: an autologous adipose tissue treatment
16.30 Dr Koenraad Blot, CMO of TiGenix, Belgium
The making of ChondroCelect: clinical and regulatory successes and challenges
17.15 Closing remarks and thanks ? SMR Chairman